Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 219 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
  My preferences 


This article has been cited by
1Methoxetamine: From drug of abuse to rapid-acting antidepressant
M. Coppola,R. Mondola
Medical Hypotheses.2012;79(4)504
2Methoxetamine: From drug of abuse to rapid-acting antidepressant
Edward C. Lauterbach,Samuel D. Shillcutt,Daniel E. Phillips
Medical Hypotheses.2016;79(4)707
3Methoxetamine: From drug of abuse to rapid-acting antidepressant
Christopher K. Merritt,Orlando J. Salinas,Alan David Kaye
Medical Hypotheses.2014;79(4)107
4An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan
Edward C. Lauterbach
Medical Hypotheses.2012;78(6)693
5Options when anti-depressants cannot be used in conventional ways. Clinical case and review of literature
Aparna Das,Crystal C. Obiozor,Deeksha Elwadhi,Michael A. Fuller
Personalized Medicine in Psychiatry.2019;15-16(6)22
6The effects of ifenprodil on the activity of antidepressant drugs in the forced swim test in mice
Ewa Poleszak,Sylwia Wosko,Anna Serefko,Aleksandra Wlaz,Regina Kasperek,Jaroslaw Dudka,Andrzej Wróbel,Gabriel Nowak,Piotr Wlaz
Pharmacological Reports.2014;66(6)1031
7The effect of imipramine, ketamine, and zinc in the mouse model of depression
Andrzej Wróbel,Anna Serefko,Piotr Wlaz,Ewa Poleszak
Metabolic Brain Disease.2015;30(6)1379